Advertisement

Index by author

February 01, 1996; Volume 24,Issue 2

  1. Adedoyin, A

    1. Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.
      Y Irshaid, R A Branch and A Adedoyin
      Drug Metabolism and Disposition February 1996, 24 (2) 164-171;

  2. Banitt, L S

    1. In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.
      Z Zhao, K A Koeplinger, G L Bundy, L S Banitt, G E Padbury, M J Hauer and P E Sanders
      Drug Metabolism and Disposition February 1996, 24 (2) 187-198;

  3. Bell, F P

    1. Biotransformation of lifibrol (U-83860) to mixed glyceride metabolites by rat and human hepatocytes in primary culture.
      E L Sun, K L Feenstra, F P Bell, P E Sanders, J G Slatter and R G Ulrich
      Drug Metabolism and Disposition February 1996, 24 (2) 221-231;

  4. Bergstrom, C P

    1. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
      C R Wagner, C P Bergstrom, K R Koning and P E Hanna
      Drug Metabolism and Disposition February 1996, 24 (2) 245-253;

  5. Branch, R A

    1. Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.
      Y Irshaid, R A Branch and A Adedoyin
      Drug Metabolism and Disposition February 1996, 24 (2) 164-171;

  6. Brennan, B

    1. Comparison of ketoconazole and fluconazole as cytochrome P450 inhibitors. Use of steady-state infusion approach to achieve plasma concentration-response relationships.
      C M Ervine, D E Matthew, B Brennan and J B Houston
      Drug Metabolism and Disposition February 1996, 24 (2) 211-215;

  7. Bundy, G L

    1. In vitro and in vivo biotransformation of 6,7-dimethyl-2,4-di-1-pyrrolidinyl-7H-pyrrolo[2,3-D]pyrimidine (U-89843) in the rat.
      Z Zhao, K A Koeplinger, G L Bundy, L S Banitt, G E Padbury, M J Hauer and P E Sanders
      Drug Metabolism and Disposition February 1996, 24 (2) 187-198;

  8. Burcham, D L

    1. Pharmacokinetics and metabolism of EXP921, a novel cognitive enhancer, in rats.
      Y N Wong, C Y Quon, K A Holm, D L Burcham, N L Frey, S M Huang and G N Lam
      Drug Metabolism and Disposition February 1996, 24 (2) 172-179;

  9. Chung, J G

    1. Kinetics of acetyl coenzyme A:arylamine N-acetyltransferase from rapid and slow acetylator frog tissues.
      C C Ho, T H Lin, Y S Lai, J G Chung, G N Levy and W W Weber
      Drug Metabolism and Disposition February 1996, 24 (2) 137-141;

  10. Decosta, K

    1. Hydroxylation of lauramide diethanolamine by liver microsomes.
      J Merdink, K Decosta, J M Mathews, C B Jones, J R Okita and R T Okita
      Drug Metabolism and Disposition February 1996, 24 (2) 180-186;
« Previous (Pages : 1 2 3 4 5 6 ... 10) Next »
Back to top

In this issue

Advertisement